Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
M Cazzola, P Rogliani, L Calzetta… - European Respiratory …, 2018 - Eur Respiratory Soc
We performed a meta-analysis to compare the impact of triple combination therapy with
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …
The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a …
CC Lai, CH Chen, CYH Lin, CY Wang… - International journal of …, 2019 - Taylor & Francis
Background This study aims to compare the effects of single inhaler triple therapy comprised
of inhaled corticosteroids (ICSs), long-acting β2-agonists (LABAs), and long-acting …
of inhaled corticosteroids (ICSs), long-acting β2-agonists (LABAs), and long-acting …
Triple inhaler versus dual bronchodilator therapy in COPD: real-world effectiveness on mortality
Randomized trials of triple therapy including an inhaled corticosteroid (ICS) for chronic
obstructive pulmonary disease (COPD) reported remarkable benefits on mortality compared …
obstructive pulmonary disease (COPD) reported remarkable benefits on mortality compared …
Triple therapy in COPD: what we know and what we don't
PMA Calverley, H Magnussen… - COPD: Journal of …, 2017 - Taylor & Francis
Triple inhaled therapy for chronic obstructive pulmonary disease (COPD) consists of an
inhaled corticosteroid (ICS), a long-acting β2-agonist (LABA) and a long-acting muscarinic …
inhaled corticosteroid (ICS), a long-acting β2-agonist (LABA) and a long-acting muscarinic …
A pooled analysis of mortality in patients with COPD receiving dual bronchodilation with and without additional inhaled corticosteroid
M Miravitlles, K Verhamme, PMA Calverley… - … journal of chronic …, 2022 - Taylor & Francis
Background Recent studies report a lower mortality rate during treatment with long-acting
muscarinic antagonist (LAMA)/long-acting β2-agonist (LABA)/inhaled corticosteroid (ICS) …
muscarinic antagonist (LAMA)/long-acting β2-agonist (LABA)/inhaled corticosteroid (ICS) …
Dual combination therapy versus long‐acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta …
Background Long‐acting bronchodilators such as long‐acting β‐agonist (LABA), long‐
acting muscarinic antagonist (LAMA), and LABA/inhaled corticosteroid (ICS) combinations …
acting muscarinic antagonist (LAMA), and LABA/inhaled corticosteroid (ICS) combinations …
Triple therapy trials in COPD: a precision medicine opportunity
S Suissa, A Ariel - European Respiratory Journal, 2018 - Eur Respiratory Soc
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy document for the
treatment of chronic obstructive pulmonary disease (COPD) suggests that, after …
treatment of chronic obstructive pulmonary disease (COPD) suggests that, after …
Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis
A Koarai, M Yamada, T Ichikawa, N Fujino… - Respiratory …, 2021 - Springer
Background Recently, the addition of inhaled corticosteroid (ICS) to long-acting muscarinic
antagonist (LAMA) and long-acting beta-agonist (LABA) combination therapy has been …
antagonist (LAMA) and long-acting beta-agonist (LABA) combination therapy has been …
Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis
Y Zheng, J Zhu, Y Liu, W Lai, C Lin, K Qiu, J Wu, W Yao - Bmj, 2018 - bmj.com
Objective To compare the rate of moderate to severe exacerbations between triple therapy
and dual therapy or monotherapy in patients with chronic obstructive pulmonary disease …
and dual therapy or monotherapy in patients with chronic obstructive pulmonary disease …
相关搜索
- long acting bronchodilator therapy
- acting bronchodilators meta analysis
- bronchodilators alone combination therapy
- patients with copd dual therapy
- pooled analysis dual bronchodilation
- bronchodilator therapy meta analysis
- dual bronchodilator therapy in copd
- acting bronchodilators combination therapy
- combination therapy meta analysis
- bronchodilators alone meta analysis
- patients with copd meta analysis
- patients with copd combination therapy
- mortality in patients dual bronchodilation